LDL-C Goals
*Only 1 answer necessary
Loading...
*Only 1 answer necessary
References
- Christiaan Vrints. 2024 ESC Guidelines for the management of chronic coronary syndromes.. European heart journal, 2024
- P. Gaba. Association Between Achieved Low-Density Lipoprotein Cholesterol Levels and Long-Term Cardiovascular and Safety Outcomes: An Analysis of FOURIER-OLE. Circulation, 2023
- Donald M Lloyd-Jones. 2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Solution Set Oversight Committee.. Journal of the American College of Cardiology, 2022
- P. Amarenco. A Comparison of Two LDL Cholesterol Targets after Ischemic Stroke.. The New England journal of medicine, 2019
- Scott M Grundy. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.. Journal of the American College of Cardiology, 2018
- Scott M Grundy. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.. Circulation, 2018
- K. Koskinas. Effect of statins and non-statin LDL-lowering medications on cardiovascular outcomes in secondary prevention: a meta-analysis of randomized trials. European Heart Journal, 2018
- M. Sabatine. Efficacy and Safety of Further Lowering of Low-Density Lipoprotein Cholesterol in Patients Starting With Very Low Levels: A Meta-analysis. JAMA Cardiology, 2018
- Michael G Silverman. Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis.. JAMA, 2016
- Reference - 10.1016/S2213-8587(19)30388-2